Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacogenetics of antiretroviral therapy.
Barreiro P, Fernández-Montero JV, de Mendoza C, Labarga P, Soriano V. Barreiro P, et al. Among authors: labarga p. Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1119-30. doi: 10.1517/17425255.2014.930128. Epub 2014 Jun 18. Expert Opin Drug Metab Toxicol. 2014. PMID: 24941049 Review.
Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy.
Barreiro P, del Romero J, Leal M, Hernando V, Asencio R, de Mendoza C, Labarga P, Núñez M, Ramos JT, González-Lahoz J, Soriano V; Spanish HIV-Discordant Study Group. Barreiro P, et al. Among authors: labarga p. J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):324-6. doi: 10.1097/01.qai.0000243091.40490.fd. J Acquir Immune Defic Syndr. 2006. PMID: 17003695
Pharmacogenetics of tenofovir treatment.
Rodriguez-Novoa S, Labarga P, Soriano V. Rodriguez-Novoa S, et al. Among authors: labarga p. Pharmacogenomics. 2009 Oct;10(10):1675-85. doi: 10.2217/pgs.09.115. Pharmacogenomics. 2009. PMID: 19842939 Review.
Viral hepatitis and HIV co-infection.
Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P. Soriano V, et al. Among authors: labarga p. Antiviral Res. 2010 Jan;85(1):303-15. doi: 10.1016/j.antiviral.2009.10.021. Epub 2009 Nov 1. Antiviral Res. 2010. PMID: 19887087 Review.
Renal toxicity associated with tenofovir use.
Rodriguez-Nóvoa S, Alvarez E, Labarga P, Soriano V. Rodriguez-Nóvoa S, et al. Among authors: labarga p. Expert Opin Drug Saf. 2010 Jul;9(4):545-59. doi: 10.1517/14740331003627458. Expert Opin Drug Saf. 2010. PMID: 20384533 Review.
Pharmacogenetics of hepatitis C.
Soriano V, Poveda E, Vispo E, Labarga P, Rallón N, Barreiro P. Soriano V, et al. Among authors: labarga p. J Antimicrob Chemother. 2012 Mar;67(3):523-9. doi: 10.1093/jac/dkr506. Epub 2011 Dec 22. J Antimicrob Chemother. 2012. PMID: 22194301
Treatment failure with new hepatitis C drugs.
Soriano V, Vispo E, Poveda E, Labarga P, Barreiro P. Soriano V, et al. Among authors: labarga p. Expert Opin Pharmacother. 2012 Feb;13(3):313-23. doi: 10.1517/14656566.2012.653341. Epub 2012 Jan 14. Expert Opin Pharmacother. 2012. PMID: 22242928 Review.
Hepatitis C therapy with HCV NS5B polymerase inhibitors.
Soriano V, Vispo E, de Mendoza C, Labarga P, Fernandez-Montero JV, Poveda E, Treviño A, Barreiro P. Soriano V, et al. Among authors: labarga p. Expert Opin Pharmacother. 2013 Jun;14(9):1161-70. doi: 10.1517/14656566.2013.795543. Epub 2013 Apr 27. Expert Opin Pharmacother. 2013. PMID: 23621117 Review.
222 results